Abbott will rapidly develop tests that can be used to help identify, isolate, and contain outbreaks when potential new virus threats are identified
With a footprint of 65,000 square meters, the new site has been designed from the ground up to accommodate demand, increasing capacity 10-fold
The findings come from the largest study to date to look at inflammatory markers in COVID-19
New line of bioreactors is designed to ensure seamless scalability from early process development to commercial manufacturing
XpressAmp Direct Amplification Reagents facilitate RNA extraction-free sample preparation that is automation-friendly
Panel designed to provide surveillance of ongoing mutations of virus that causes COVID-19
The first 510(K)-cleared transport medium for COVID-19 testing
Assistant professor and materials scientist Dr. Abhay Dasadia shares his passion for sharing knowledge in this week’s Reviewer in the Spotlight
